These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1409187)

  • 1. Autoimmunity and glomerulonephritis.
    Saxena R; Johansson C; Bygren P; Wieslander J
    Postgrad Med J; 1992 Apr; 68(798):242-50. PubMed ID: 1409187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibodies as serological markers in the diagnosis of glomerulonephritis].
    Saxena R; Johansson C; Bygren P; Wieslander J
    Lakartidningen; 1992 Jan; 89(3):117-20. PubMed ID: 1734140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity in nephritis.
    Ballardie FW
    Autoimmunity; 1990; 6(4):319-28. PubMed ID: 2104179
    [No Abstract]   [Full Text] [Related]  

  • 4. Entactin: a possible auto-antigen in the pathogenesis of non-Goodpasture anti-GBM nephritis.
    Saxena R; Bygren P; Butkowski R; Wieslander J
    Kidney Int; 1990 Aug; 38(2):263-72. PubMed ID: 2119467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

  • 6. New advances in understanding the treatment of glomerulonephritis.
    Lockwood CM
    Clin Nephrol; 1986; 26 Suppl 1():S76-80. PubMed ID: 3829472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual pattern of immunofluorescence positivity.
    Nasr SH; Ilamathi ME; Markowitz GS; D'Agati VD
    Am J Kidney Dis; 2003 Aug; 42(2):419-26. PubMed ID: 12900828
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmunity and glomerulonephritis.
    Lockwood CM; Bowman C; Bakes D; Pressey A; Dash A
    Adv Nephrol Necker Hosp; 1987; 16():291-306. PubMed ID: 3101428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunopathogenesis of glomerulonephritis--new data on the clinical and experimental studies].
    Krzymański M
    Przegl Lek; 1992; 49(1-2):10-2. PubMed ID: 1454997
    [No Abstract]   [Full Text] [Related]  

  • 12. Glomerulonephritis induced by antibody directed against glomerular basement membrane.
    Martini A
    Paediatrician; 1981; 10(5-6):368-81. PubMed ID: 7329701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
    Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J
    Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental autoimmune antiglomerular basement membrane (GBM) antibody induced glomerulonephritis (GN) by immunization with rat GBM antigen derived from Masugi nephritis in Wistar rats].
    Saito K; Totsuka D; Soeda K; Takase S; Kawasumi H; Shibata T; Uchida J; Kitazawa K; Yamamoto J; Yonekura M
    Nihon Jinzo Gakkai Shi; 1983 Nov; 25(11):1299-315. PubMed ID: 6674648
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic apheresis for renal diseases.
    Harada T; Miyazaki M; Ozono Y; Sasaki O; Shioshita K; Kohno S; Nishikido M; Saito Y; Taguchi T
    Ther Apher; 1998 Aug; 2(3):193-8. PubMed ID: 10227769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction of human IgG subclass expression in the population of auto-antibodies to glomerular basement membrane.
    Bowman C; Ambrus K; Lockwood CM
    Clin Exp Immunol; 1987 Aug; 69(2):341-9. PubMed ID: 3652535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of cellular immunity in the pathogenesis of glomerulonephritis].
    Kacprzyk F; Orłowski Z
    Postepy Hig Med Dosw; 1989; 43(2-4):199-212. PubMed ID: 2702352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antinuclear antibodies in IgA nephropathy, as well as mesangiocapillary and membranous glomerulonephritis].
    Nagy J; Goshen E; Livne A; Sarov I; Shoenfeld Y
    Orv Hetil; 1991 Mar; 132(12):623-8. PubMed ID: 2011384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What is the role of autoimmune processes in nephropathies?].
    Ehrich JH; Oemar BS; Bruijn JA
    Monatsschr Kinderheilkd; 1990 Nov; 138(11):724-9. PubMed ID: 2290431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.